SANN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Santhera Pharmaceuticals Holding AG

Watchlist Manager

Watchlist

Price: 16 CHF -0.74% Market Closed

Market Cap: CHf242.4m

S	Santhera Pharmaceuticals Holding AG SIX:SANN	CH
	HCA Healthcare Inc NYSE:HCA	US
A	Abbott Laboratories SIX:ABT	US
	Soleno Therapeutics Inc F:6XC	US
F	Flutter Entertainment PLC ISEQ:FLTR	IE
T	Tencent Holdings Ltd F:NNN1	CN
	First Citizens BancShares Inc (Delaware) NASDAQ:FCNCA	US
M	Marubeni Corp OTC:MARUY	JP
S	Sany Heavy Equipment International Holdings Company Ltd XMUN:YXS	CN

Profitability Summary

Santhera Pharmaceuticals Holding AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

13%

Strong 3Y Average Gross Margin

59%

Declining Gross Margin

52% > 13%

Negative Operating Margin

-104%

Negative 3Y Average Operating Margin

-196%

Operating Margin is Increasing

-696% > -104%

Negative Net Margin

-134%

Negative 3Y Average Net Margin

-277%

Net Margin is Increasing

-951% > -134%

Negative Free Cash Flow Margin

-84%

Negative 3Y Average Free Cash Flow Margin

-155%

Free Cash Flow Margin is Increasing

-452% > -84%

Negative ROE

-136%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

ROIC is Increasing

-87% > -66%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.